HomeEBS • NYSE
Emergent Biosolutions Inc
$9.73
Jan 13, 9:39:07 AM GMT-5 · USD · NYSE · Disclaimer
StockUS listed securityUS headquartered
Previous close
$9.88
Day range
$9.67 - $9.73
Year range
$1.42 - $15.10
Market cap
524.50M USD
Avg Volume
1.04M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
293.80M8.61%
Operating expense
92.20M-3.96%
Net income
114.80M143.58%
Net profit margin
39.07140.12%
Earnings per share
1.37
EBITDA
97.70M319.31%
Effective tax rate
19.38%
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
149.90M70.73%
Total assets
1.48B-21.94%
Total liabilities
969.40M-18.94%
Total equity
508.40M
Shares outstanding
54.18M
Price to book
1.05
Return on assets
12.03%
Return on capital
14.71%
Net change in cash
(USD)Sep 2024Y/Y change
Net income
114.80M143.58%
Cash from operations
153.70M156.17%
Cash from investing
112.00M692.59%
Cash from financing
-180.30M-319.30%
Net change in cash
85.40M10,775.00%
Free cash flow
154.31M111.86%
About
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid. During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
Founded
Sep 5, 1998
Employees
1,600
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu